Pay in 4 interest-free payments of $5.75 Learn more
Ships within 48 hours · Estimated delivery Nov 17 - Nov 22
An expert is available to answer questions about the status of a substance or method, as well as Therapeutic Use Exemptions (TUE) and how that process can be started or carried out
10.1016/j.ebiom.2023.104494 9 ChenM.WeiS.WuX.XiangZ.LiX.HeH.et al (2024)
The method of embodiment 160, wherein the chemotherapy-induced ototoxicity is caused by a platinum based chemotherapeutic agent, a bis-platinate, vincristine, an aminoglycoside antibiotic, a macrolide antibiotic, a diuretic or a salicylate
Injection site reactions represent the primary side effect, and these are typically manageable with proper technique
1419), stable in human gastric juice, accordingly investigated in trials for inflammatory bowel disease, wound treatment, with no toxicity reported, where LD1 could be not achieved, effective alone without carrier (5-7, 9)
US$ 21.43
US$ 21.84
US$ 22.27
